No black box warning on record for Carbamazepine

As of the latest FDA labeling reviewed, Carbamazepine (CARBAMAZEPINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Carbamazepine medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Serious Dermatologic Reactions Serious and sometimes fatal dermatologic reactions, including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), have been reported with carbamazepine treatment. The risk of these events is estimated to be about 1 to 6 per 10,000 new users in countries with mainly Caucasian populations. However, the risk in some Asian countries is estimated

No black box warning on record for Carbamazepine

Other warnings & precautions

WARNINGS Serious Dermatologic Reactions Serious and sometimes fatal dermatologic reactions, including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), have been reported with carbamazepine treatment. The risk of these events is estimated to be about 1 to 6 per 10,000 new users in countries with mainly Caucasian populations. However, the risk in some Asian countries is estimated

Carbamazepine Black Box Warning

No black box warning on record for Carbamazepine

Other warnings & precautions

Carbamazepine Black Box Warning

No black box warning on record for Carbamazepine

Other warnings & precautions